The present specification provides novel ginsenosides (20S, 24R) -6-O-β-D-glucopyranosyl (1->； 2) -β-D-glucopyranoside-damar-3-one-20, 24-epoxy-6a, 12b, 25-triol ((20S, 24R) -6-O-β-D-glucopyranosyl (1->； 2) -β-D-glucopyranoside-dammar-3-one-20,24 -epoxy-6a, 12b, 25-triol), pharmaceutically acceptable salts thereof, hydrates thereof or solvates thereof. The novel ginsenosides exhibit an excellent anti-inflammatory effect.본 명세서는 신규 진세노사이드인 (20S,24R)-6-O-β-D-글루코피라노실(1->；2)-β-D-글루코피라노사이드-다마르-3-원-20,24-에폭시-6a,12b,25-트리올 ((20S,24R)-6-O-β-D-glucopyranosyl(1->；2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol), 이의 약학적으로 허용가능한 염, 이의 수화물 또는 이의 용매화물에 관한 것이다. 상기 신규 진세노사이드는 우수한 항염효과를 나타낸다.
